Clinical Trials Directory

Trials / Sponsors / EndoCeutics Inc.

EndoCeutics Inc.

Industry · 9 registered clinical trials.

StatusTrialPhaseStarted
WithdrawnPrasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - Second Study
Hypoactive Sexual Desire Disorder (HSDD)
Phase 32018-11-13
WithdrawnEffect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for
Vaginal Atrophy in Breast Cancer Patients
Phase 32018-11-06
CompletedPrasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Hypoactive Sexual Desire Disorder
Phase 32017-10-16
CompletedIntravaginal Prasterone (DHEA) Against Vulvovaginal Atrophy Associated With Menopause
Vaginal Atrophy
Phase 32014-02-01
CompletedDehydroepiandrosterone (DHEA) + Acolbifene Against Vasomotor Symptoms (Hot Flushes) in Postmenopausal Women
Vasomotor Symptoms, Hot Flushes
Phase 32011-10-01
CompletedDehydroepiandrosterone (DHEA) Against Vaginal Atrophy
Vaginal Atrophy
Phase 32011-06-01
CompletedDHEA Against Vaginal Atrophy - Safety Study of 12 Months
Vaginal Atrophy
Phase 32010-12-01
CompletedDHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Vaginal Atrophy
Phase 32010-12-01
CompletedTopical DHEA Against Vaginal Atrophy
Vaginal Atrophy
Phase 32007-06-01